Telomeres as targets for anticancer therapies

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• Cancer cell immortality relies on telomere integrity and maintenance mechanisms.
• Two primary mechanisms exist in human cancers: telomerase activity and the alternative lengthening of telomeres (ALT) pathway.
• Telomere maintenance is crucial for tumor cell proliferation, making it an attractive therapeutic target.

Purpose of the Study:

• To review current therapeutic strategies targeting telomere maintenance mechanisms in cancer.
• To discuss challenges in developing broad-spectrum anticancer therapies based on telomere targeting.
• To explore the potential of targeting telomeric G-quadruplex structures as an anticancer strategy.

Main Methods:

• Review of existing literature on telomere maintenance and anticancer therapeutic strategies.
• Analysis of clinical trial data for telomere-targeting agents, such as GRN163L.
• Evaluation of evidence supporting G-quadruplex structures as a therapeutic target.

Main Results:

• The oligonucleotide GRN163L is the only telomere-targeting agent currently in clinical trials.
• Targeting telomeric G-quadruplex structures shows promise as a therapeutic strategy.
• This approach may be effective regardless of the specific telomere maintenance pathway active in the tumor.

Conclusions:

• Telomere maintenance mechanisms are vital targets for novel anticancer interventions.
• Developing clinically applicable telomere-based therapies faces significant challenges.
• Targeting G-quadruplex structures represents a potential broad-spectrum anticancer therapeutic avenue.